# Sihf Healthcare

Health Center, IL
Page: https://astrelis.co/providers/health_center/141832  
This twin: https://astrelis.co/providers/health_center/141832.md  
CMS Certification Number (CCN): 141832  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2021)

- **Total patients (UDS) (FY2024):** 103,257. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2021):** -66.9%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 52. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 8.3%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2021):** $40.6M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2021):** +16.3%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### SOUTHERN ILLINOIS HEALTHCARE FOUNDATION, INC., IL

Match to this profile: matched by name (method: name and state).

- FY ending 2025-12-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000417079
- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000367770
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000040227

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 18,916,377 [derived, p.6] | 13,367,554 [derived, p.6] | 23,099,427 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 5,865,039 [derived, p.6] | 5,463,012 [derived, p.6] | 5,686,528 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 1,011,101 [derived, p.6] | 536,112 [derived, p.6] | 212,502 [derived, p.6] |
| other current assets (Statement of financial position) | 1,005,045 [derived, p.6] | 1,300,271 [derived, p.6] | 995,964 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 26,797,562 [extracted, p.6] | 20,666,949 [extracted, p.6] | 29,994,421 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 31,261,755 [derived, p.6] | 31,782,317 [derived, p.6] | 26,033,205 [derived, p.6] |
| other long-term assets (Statement of financial position) | 41,531,741 [derived, p.6] | 35,090,958 [derived, p.6] | 33,950,909 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 99,591,058 [extracted, p.6] | 87,540,224 [extracted, p.6] | 89,978,535 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 8,764,317 [derived, p.6] | 8,160,703 [derived, p.6] | 8,639,114 [derived, p.6] |
| deferred revenue (Statement of financial position) | 1,398,958 [derived, p.6] | 672,747 [derived, p.6] | 1,070,613 [derived, p.6] |
| current debt and leases (Statement of financial position) | 1,851,616 [derived, p.6] | 1,561,666 [derived, p.6] | 1,600,329 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 12,014,891 [extracted, p.6] | 10,395,116 [extracted, p.6] | 11,310,056 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 16,039,055 [derived, p.6] | 4,382,447 [derived, p.6] | 5,604,990 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | 287,792 [derived, p.6] | 287,792 [derived, p.6] | 287,792 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 28,341,738 [extracted, p.6] | 15,065,355 [extracted, p.6] | 17,202,838 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 71,249,320 [derived, p.6] | 72,474,869 [derived, p.6] | 72,775,697 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 71,249,320 [extracted, p.6] | 72,474,869 [extracted, p.6] | 72,775,697 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 50,954,207 [derived, p.7] | 50,421,078 [derived, p.7] | 43,555,958 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 12,914,454 [derived, p.7] | 14,097,791 [derived, p.7] | 15,842,754 [derived, p.7] |
| federal grants (Statement of activities) | 18,629,899 [derived, p.7] | 18,376,578 [derived, p.7] | 23,308,536 [derived, p.7] |
| other grants and contracts (Statement of activities) | 795,902 [derived, p.7] | 949,263 [derived, p.7] | 1,027,183 [derived, p.7] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 5,191,923 [derived, p.7] | 6,130,569 [derived, p.7] | 4,933,855 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 88,486,385 [extracted, p.7] | 89,975,279 [extracted, p.7] | 88,668,286 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 64,093,281 [derived, p.7] | 64,305,238 [derived, p.7] | 56,454,471 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 4,862,446 [derived, p.7] | 5,605,443 [derived, p.7] | 7,256,233 [derived, p.7] |
| purchased and professional services (Statement of activities) | 16,822,628 [derived, p.7] | 18,117,384 [derived, p.7] | 15,705,173 [derived, p.7] |
| occupancy (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | 2,918,625 [derived, p.7] | 2,731,631 [derived, p.7] | 2,365,913 [derived, p.7] |
| interest (Statement of activities) | 615,336 [derived, p.7] | 29,724 [derived, p.7] | 46,718 [derived, p.7] |
| other expenses (Statement of activities) | 1,409,618 [derived, p.7] | 1,392,903 [derived, p.7] | 1,129,958 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 90,721,934 [extracted, p.7] | 92,182,323 [extracted, p.7] | 82,958,466 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | -2,235,549 [extracted, p.7] | -2,207,044 [extracted, p.7] | 5,709,820 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 1,010,000 [derived, p.7] | 1,906,216 [derived, p.7] | 4,269,314 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | -1,225,549 [extracted, p.7] | -300,828 [extracted, p.7] | 9,979,134 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 72,474,869 [extracted, p.7] | 72,775,697 [extracted, p.7] | 62,796,563 [extracted, p.7] |
| net assets, end (Statement of activities) | 71,249,320 [extracted, p.7] | 72,474,869 [extracted, p.7] | 72,775,697 [extracted, p.7] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 79 days [plausible] | 55 days [plausible] | 105 days [plausible] |
| Current ratio | 2.23x [plausible] | 1.99x [plausible] | 2.65x [plausible] |
| Operating margin | -2.5% [plausible] | -2.5% [plausible] | 6.4% [plausible] |
| Total margin | -1.4% [plausible] | -0.3% [plausible] | 11.3% [plausible] |
| Patient revenue share | 57.6% [plausible] | 56.0% [plausible] | 49.1% [plausible] |
| Grant dependency | 22.0% [plausible] | 21.5% [plausible] | 27.4% [plausible] |
| Salaries share | 70.6% [plausible] | 69.8% [plausible] | 68.1% [plausible] |
| Days in patient receivables | 42 days [plausible] | 40 days [plausible] | 48 days [plausible] |
| Debt to net assets | 0.25x [plausible] | 0.08x [plausible] | 0.10x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (SOUTHERN ILLINOIS HEALTHCARE FOUNDATION, INC.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Sihf Healthcare", https://astrelis.co/providers/health_center/141832, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.